关于我们
图片名称

News

The public service platform project for the industrialization of innovative achievements in the field of medical equipment has been settled in China Africa international pharmaceutical industry cooperation park


On March 26, 2021, the launching meeting of the Ministry of industry and information technology's "2020 industrial technology based public service platform project - public service platform for the industrialization of innovative achievements in the field of medical equipment" was held in Taizhou. Shu min, deputy director of the industrial development promotion center of the Ministry of industry and information technology, Jin Xin, a first-class researcher of the Department of economy and information technology of Zhejiang Province, Chen Tingchen, vice mayor of Taizhou Municipal People's government, attended the meeting and delivered a speech. Zhao Shouming, chairman of wanbond Medical Technology Co., Ltd., and other representatives of project cooperation units attended the meeting.
"Public service platform for the industrialization of innovative achievements in the field of medical equipment" is a sub project of the "2020 basic public service platform for industrial technology - construction project of public service platform for the industrialization of innovative achievements in key fields of manufacturing" of the Ministry of industry and information technology of the people's Republic of China. The project was signed on August 1, 2020 and led by wanbond Medical Technology Co., Ltd, It is jointly constructed by the Institute of mechanical industry information, Beijing Hagong Huiyu artificial intelligence technology development Co., Ltd., Institute of comprehensive technology and economy of mechanical industry instruments, Zhejiang Youyi Medical Instrument Co., Ltd., mede Medical Industrial Equipment Co., Ltd. and Shanghai lishengte medical science and Technology Co., Ltd.
According to the agreement, the two sides will jointly promote the development of the whole industrial chain in the field of high-end medical equipment in China, build a public service platform and improve public service capacity; Improve the technical foundation of the industry, focus on the research and development of common problems of key technologies, accelerate the transformation of scientific research achievements and industrialization, and create a through train for the connection of industry and finance; Improve the construction of industry standard system and promote the upgrading of the industry. The total investment of the project is 59 million yuan, including 17.7 million yuan allocated by the state, 17.7 million yuan for local supporting facilities and 23.6 million yuan raised by the enterprise itself.
At the exchange session, experts and scholars such as Professor Duan Xingguang of the Institute of robotics of Beijing University of technology, Professor Ye Xuesong of the school of Biomedical Engineering and instrument science of Zhejiang University, and He Tao, executive vice president of Zhejiang medical device industry association also made exchange speeches on the future development prospect of China's medical equipment industry.
At the meeting, the project was signed. Wanbond Medical Technology Co., Ltd. and Taizhou Research Institute of Zhejiang University signed an agreement on strengthening innovation cooperation in the field of medical equipment, which aims to further promote school enterprise exchanges and cooperation in the field of medical equipment, and guide the flow and agglomeration of advantageous discipline resources and innovation elements of Zhejiang University and Taizhou Research Institute to enterprises, Carry out industry university research cooperation such as key technology research and new product development, and strengthen the transformation of scientific research achievements. At the same time, jointly train talents to realize the connection between supply and demand of engineering and technical talents in the field of medical equipment in Taizhou.
Wanbond Group Co., Ltd. and Anhui Enhe Biotechnology Co., Ltd. (hereinafter referred to as Enhe Biotechnology) signed a cooperation agreement on accelerating the business development of in vitro diagnostic reagents of Zhejiang taiste Biotechnology Co., Ltd. (hereinafter referred to as taiste). With the signing of this agreement, in addition to the overall relocation and settlement in the China Africa international pharmaceutical industry cooperation Park, taiste will also introduce the national leading industrialization technology of characteristic in vitro diagnostic reagents (including 14 patented technologies) for the diagnosis of liver function, tumors, brain lesions and other diseases in the production and Research of Enhe biology, so as to realize large-scale production in the industrial park.
After the meeting, the participants successively visited the China Africa international pharmaceutical industry cooperation Park of the platform construction base. Deeply understood the development advantages of the industrial cooperation Park in many fields such as artificial bone devices, polymer medical devices, medical protective articles, virus diagnostic reagents, artificial intelligence industrialization technology, agent sales of a full range of medical devices and maintenance technical services, and fully affirmed the development prospect of the project consortium. It is hoped that all parties involved in the project will make concerted efforts during the implementation of the project, coordinate development, strengthen innovation, constantly improve the project construction objectives, earnestly implement the work of all parties, make every effort to build a public service platform and continue to promote the high-quality development of the medical equipment industry.